News

One of a series of articles forming a special supplement in PHA on antimicrobial resistance in Nepal.

One of a series of articles forming a special supplement in PHA on antimicrobial resistance in Nepal.

One of a series of articles forming a special supplement in PHA on antimicrobial resistance in Nepal.

The Bill to ban heated tobacco products in Hong Kong has been delayed, causing the authors to write to the IJTLD highlighting the risks of introducing new tobacco products. The preprint is free to read.

Dr Christopher Zishiri MBCHB MPH FFPH (UK) was a gifted public health professional, who devoted his time and energy to the strengthening…

The Union with the European Respiratory Society (ERS) and partner organisations have written to the World…

This week marks the 100th anniversary of the Bacille Calmette-Guérin (BCG) vaccine, yet the fight to end tuberculosis (TB) remains.…

On 18 July 1921, a newborn baby received a dose of an experimental vaccine called Bacille Calmette-Guérin (BCG). Fast forward 100 years and it is the most widely used vaccine globally – billions of children have been vaccinated and countless children’s lives have been saved worldwide.

In this State of the Art, the authors reviewed the literature on thromboembolic adverse events reported after vaccination for COVID-19, and review the benefits and risks of the vaccines approved for use. The preprint is free to read.

This week, The Union conducted capacity building training for community volunteers in Myanmar to improve their counselling skills by…

On 18th July 2021, we celebrate the 100th anniversary of the first use of the BCG vaccine for TB. An Editorial in IJTLD discusses BCG’s efficacy, heterologous protection and controversial link with COVID-19. The preprint is free to read.

An Editorial for IJTLD highlights the importance of TB preventive treatment (TPT) and the launch by WHO, governments, civil society and other partners of a ‘Call to Action’ for broader access to TPT for those in need. The article is free to read.

In this Correspondence accepted article for IJTLD, the authors found a 67.4% decrease in testing, a 66.9% decrease in bacteriologically confirmed (bac+) diagnosis and a 58.9% decrease in diagnosis of all forms TB. The preprint is free to read.

In this recently accepted article for IJTLD, the authors found that RR-TB diagnosis decreased by 21–38% following the start of the pandemic. The results are disturbing and suggest that COVID-19 has had a sustained impact at a time when household transmission of TB/RR-TB might have increased due to ‘shelter at home’. The preprint is free to read.

In its fight against lifesaving tobacco control policies—increased taxes, larger pictorial health warnings, and advertising bans—the…

Noncommunicable diseases (NCDs), including cardiovascular diseases, diabetes, cancer, and chronic respiratory diseases and their four…

After nearly a decade, the commitment and perseverance of tobacco control advocates including The Union will dramatically alter Jakarta’…